Printer Friendly

Histological Changes in the Fetal Brain of Albino Mouse after Maternal Treatment with Panax ginseng.

Byline: Sarah Khalid, Mohammad Tahir and Khalid P. Lone

Abstract

This study was conducted to evaluate the efficacy and safety of a herb Panax ginseng. It was found that maternal treatment with Panax ginseng negatively affected the fetal brain and increased the glial cells with a concomitant reduction in number of neurons. Although in vitro embryotoxicity may not reflect the true situation in humans, further investigation and monitoring of the adverse effects of the ginseng during pregnancy are warranted. Herbal therapies should not be used indiscriminately unless there is adequate evidence of their safety and efficacy.

Key words: Neurons, neuroglia, Panax ginseng, fetal brain, anomalies.

INTRODUCTION

The history of herbal medicine practice is as old as the civilization itself. Amid the various herbal medicines practiced in the world, ginseng is one of the commonly used and highly researched herbs (Kiefer and Pantuso, 2003), as it contains the maximum number of active constituents and has the most extensive pharmacological effects and specific mechanism of actions (Cheng et al., 2005). Panax ginseng is regarded as a tonic with adaptogenic stimulant and aphrodisiac properties (Attele et al., 1999). It enhances phagocytosis, improves physical and mental performance, increases resistance to exogenous stress factors and affects hypoglycemic activity (Kiefer and Pantuso, 2003). The recognized primary active components of ginseng are a group of 30 different triterpene saponins, also referred to as ginsenosides, which vary in content and relative proportions among different species of ginseng.

Based on the dammarane structure more than forty ginsenosides have been identified, and one ginsenoside Ro is derived from Olenoic acid (Nah, 1997; Kitts and Hu, 2003). The dammarane saponins are derivatives of either protopanaxadiol or protopanaxatriol; commonly available ginseng extracts usually contain a mixture of ginsenosides, and GRb1, GRc, GRe, and GRg1 are present in high concentrations (Liu et al., 2006). Of numerous ginsenosides that have been identified six (Rb1, Rb2, Rc, Rd, Re, and Rg1) have been chosen for reference standards for ginseng products. The concentration of any individual ginsenoside varies based on the source, plant part and time of year harvested (Coleman et al., 2003) . Recent studies have also identified an acidic polysaccharide referred to as "Ginsen' with noted immuno-stimulatory activity. Other constituents present in the root extract are volatile oils, anti-oxidants, polysaccharides, fatty acids, vitamins, heavy metals and polyacetylenes (Kitts and Hu, 2003).

The mechanism by which the herbal remedy exerts its effects is most likely through hypothalamic-hypophysial-adrenal axis and through immunostimulation (Kwon et al., 2003). Ginsenoside produce different effects from one another, with each ginsenoside having the power to initiate multiple actions in the same tissue. These results create an overall complex pharmacological picture (Coleman et al., 2003).

It is generally believed that natural herbal medicines are better and safer than conventional medicine. Herbal medicines are in fact associated with serious toxic effects (Ong et al., 2005). Up to 64% of women are reported taking herbal supplements including ginseng during their pregnancy. Despite widespread usage of ginseng during pregnancy, information concerning the potential effects of ginseng on the developing fetus in vivo are lacking. Various in vitro studies prove that ginsenoside exert direct teratogenic effects on rat and mouse embryos and there is a significant variability in embryotoxic effects of different ginsenoside (Liu et al., 2006; Chan et al., 2003; Chan et al., 2004; Liu et al., 2006; Liu et al., 2005; Ashmaoui et al., 2003).

Most published research studies have used a standardized ginseng extract in a dosage of 200 mg per day. Capsule formulas are generally given at a dose of 100-600 mg per day usually in divided doses (Kitts and Hu, 2003). The maximum tolerated dose of ginseng as descried by the European Committee for Herbal Medicines is 2-9g/day (EAEMP, 1999).

This study was designed to determine toxic effects of Panax ginseng, if any, on the fetal brain of mouse.

MATERIALS AND METHODS

Thirty albino mice (twenty-four female and six males) 6-8 weeks old were procured from the National Institute of Health, Islamabad. All the animals were examined thoroughly and weighed before the commencement of the experiment. The mice were housed in the Research Laboratory of University of Health Sciences, Lahore under controlled conditions. Female mice were left overnight for mating, the pregnancy was confirmed the following morning by the presence of vaginal plug and this was considered as gestational day-0 (zero). Pregnant mice were randomly divided into three groups; each group contained eight female and two male mice. Each group was further divided into two subgroups comprising of four female mice and one male mouse each.

Commercially available Panax ginseng root powder containing 3% ginsenoside was obtained from Sigma (USA). The dosage of ginseng was determined by maximum tolerated dose (MTD), and human therapeutic dose (HTD) According to the rule of surface area ratio and an increased metabolic rate observed in albino mice, the human therapeutic dose of ginseng for mouse was calculated as 780mg/kg/day, and the maximum tolerated dose of ginseng calculated was 1560mg/ kg/day.

Following three groups were used in the experiment, Group 1 (control group) which was given 0.1ml of distilled water orally throughout pregnancy, Group 2 (low dose treated group), which was given orally throughout pregnancy the human therapeutic dose of ginseng (780 mg/kg/day) dissolved in 0.1ml of distilled water, and Group 3 (high dose treated group), which was given orally throughout pregnancy the maximum tolerated dose of ginseng (1560 mg/kg/day) dissolved in 0.1ml of distilled water.

The drug was given throughout the pregnancy and at term the fetusus were checked for any gross abnormalities and fixed in 10% buffered formalin for histological studies. Routine histological technique and procedure were followed and sections were cut at 5-6 um thickness and stained with haematoxylin and eosin.

Statistical analyses

The statistical analyses were carried out using computer software Statistical Package for Social Sciences (SPSS) version 13. The difference was regarded statistically significant if the 'p' value was < 0.05.

RESULTS

The fetal heads were grossly well formed and did not manifest any malformations of brain or the spinal cord. Transverse sections of the whole fetal skull were taken and the area selected for counting neurons and neuroglia was adjacent to the cavity of third ventricle at the level of pinna. The numbers of neurons as well as neuroglia were counted using a 10 x 10 reticule under 40X objective magnification.

In the histological sections of both the treated and control groups the large multi -polar neurons were dispersed among the neuroglial cells and were characterized by numerous processes extending in different directions from the perikaryon or the cell body (Fig. 1).

The average number of neurons present in the transverse section was 27 per mm2 in the low dose (n=47) treated group (Fig. 2), 20 per mm2 in the high dose (n=43) treated group (Fig. 3) as compared to 35 per mm2 (n=52) in the control group (Fig. 1). The difference in the number of neurons seen in the treated groups compared with the control group was statistically significant (p <0.05).

The neuroglia constitute the supporting frame work of the nervous system; and were seen as deeply staining bodies that were smaller in size than the multipolar neurons. Both the fibrous and protoplasmic astrocytes were markedly increased in number, with the number much more in the high dose treated group. Fibrous astrocytes were seen in the vicinity of the blood capillaries and exhibited a small cell body, large oval nucleus and a dark staining nucleolus with processes extending from the perikaryon. Protoplasmic astrocytes were characterized by their abundance of cell processes and a smaller size of the perikaryon (Fig. 1).

The ventricles were lined by ependymal cells that were high cuboidal to columnar in shape. The nuclei of the ependymal cells were darkly staining and oval to round in architecture. Long axis of the ependymal cells was perpendicular to the long axis of the cavity. The ependymal cells observed in the treated groups were not as well formed as seen in the control group. The nuclei at places were seen to form aggregates and the cilia were less frequently observed (Fig. 4). (3).

Also evident in the photomicrograph is dispersed white matter and un-differentiated connective tissue (4), 300 X; H and E.

The neuroglial cells of ectodermal origin, i.e., astrocytes, oligodandrocytes and ependymal cells were in abundance in the treated groups as compared to the control group (Figs. 2, 3). The number of the neuroglia (astrocytes and oligodandrocytes) was 57per mm2 in the low dose (n=47) treated group, 95 per mm2 in the high dose (n=43) treated as compared to 43 per mm2 in the control (n=52) group. The abundance in the number of neuroglia seen in the treated groups compared with the control group was statistically significant (p <0.05).

The white matter dispersed in between the neurons and neuroglia appeared to be well formed but less in amount as seen in the treated groups when compared to the control group (Fig. 5).

There was also evidence of un-differentiated connective tissue, present in the vicinity of the ventricles, in the treated groups (Fig. 6).

DISCUSSION

In recent years assessment of the safety and efficacy of these alternate therapies is an important issue for the health professions. Literature review has elicited a controversy regarding beneficial role of Panax ginseng. Panax ginseng is documented to repair the damaged tissues of kidney, liver, brain and endothelial cells (Kitts and Hu, 2003). On the other hand, constitutes of herbal medicines are considered toxic resulting in liver, kidney or other tissue damage (Fogden and Neuberger, 2001; Va'zqquez and Aguera-Oritz, 2002).

Histological examinations of fetal brain in situ demonstrated an untoward increase in the number of neuroglial cells. This increase was dose dependant with the highest number seen in the high dose treated group. The altered ratio between the neurons and neuroglia might be a result of an increased production of neuroglial cells or it might be a result of degeneration or apoptosis of the neurons. Stem cells are capable of proliferation, self renewal and production of differentiated functional progeny that are characteristic of the organ from which they were derived (Hall and Watt, 1989) . The proliferation and differentiation of neural stem cells are under the control of various intracellular and extracellular signaling molecules and growth factors (Weissmann, 2000; Chan et al., 2002).

The exogenous small molecules that can mimic the activity of the growth factors could, in principle, induce neurogenesis or gliogenesis in situ, in the brain and the endogenous neural stem cells (Dai and Holland, 2003; Connor and Dragunow, 1998; Kruger and Morrison, 2002). In a recent study it was shown that Ginsenoside Rd promoted the production of astrocytes from neurospheres in treated groups with regard to control, and the relative production of neurons was decreased as compared to control group. It was concluded that Rd could play a role on neuron/glia differentiation pathway resulting in differentiation of neual stem cells into astrocytes (Shi et al., 2005; Jeong and Nah, 2005). These are in accordance with our findings suggesting that ginsenoside may influence the neural progenitor cells during the developmental process resulting in an increased number of glial cells.

Also evident in the sections of brain were loci of un-differentiated connective tissue. These loci were statistically significant (p<0.05) in treated groups as compared with the control group. Ginseng possesses cytotoxic activity that is also the basis for its anticancer activity (Shibata, 2001; Chang et al., 2003). The cytotoxic activity of ginseng probably arrested the growth of mesenchymal cells into their mature form.

Herbal remedies and alternative medicines are used throughout the world and in the past herbs were often the original sources of most drugs. Complementary and alternate medicines (CAM) are widely used in affluent countries such as USA, Canada, UK, Germany and Australia and are taken not only for curative but also for preventive purposes (Wilson et al., 2006). It seems that less than half of people using CAM therapies do, in fact, have disorders for which they seek cure (Matsuda et al., 2003). The usage of herbal remedies is reported to be more frequent in women than in men, more frequent amongst middle-aged than elderly people, and more frequent amongst well- educated than low-educated individuals. In a recent survey it was seen that 9.1% pregnant women consumed herbal remedies including ginseng during their pregnancy. This percentage was raised to 10 in Asian countries (Grieve, 2005).

The unguarded rise in use of herbal medicines raises a question as to how safe are these preparations for the unborn fetus. The dilemma facing most regulatory authorities is that the public considers these products as either traditional medicines or natural products that are safe for consumption and require no regulation what so ever. Most countries have laws concerning foods, drugs, and cosmetics. It is our ill-fate that such laws are not established in Pakistan. Our society has no hindrances in procuring these remedies as these are considered safer and better than most of the conventional or allopathic medicines. If we adopt a causal attitude to the potential embryotoxic affects of ginsenoside, it might induce some kind of severe consequence in humans, such as low birth weight infant or even abnormality of spirit and behavior etc (Weissmann, 2000).

REFERENCES

ASANUMA, Y. AND KUBO, M., 2003. Promotion of hair growth by ginseng radix on cultured mouse vibrissal hair follicles. Phytother. Res., 17: 797 - 800.

ASHMAOUI, H.M.E, GIRGIS, S.M. AND RAOUF, A.E., 2003. Evaluation of the potential mutagenic effects of ginseng on maternally treated post-implanted mouse fetuses. Egyptian J. Hosp. Med., 13: 57-65.

ATTELE, A.S. AND WU, J.A. AND YUAN, C.S., 1999. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pahrmacol., 58:1685- 1693.

CHAN, L.Y, CHIU, P.Y. AND LAU, T.K., 2003. An in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model. Hum. Reprod., 18: 2166-2168.

CHAN, L.Y, CHIU, P.Y. AND LAU, T.K., 2004. Embryotoxicity study of ginsenoside Rc and Re in in-vitro rat whole embryo culture. Reprod. Toxicol., 19: 131-134.

CHAN, R.Y.K., CHEN, W.F., DONG, A., GUO, D. AND WONG, M.S., 2002. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J. Clin. Endocrinol. Metab., 87: 3691-3696.

CHANG, Y., SEO, E., GYLLENHAAL, C. AND BLOCK, K., 2003. Panax ginseng: a role in cancer therapy. Integ. Therap., 2: 13-33.

CHENG, Y., SHEN, L. AND ZHANG, J., 2005. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacologica Sinica 26:143-149.

COLEMAN, C.I., HEBERT, J.H. AND REDDY, P., 2003. The effects of Panax ginseng on quality of life. J. Clin. Pharm. Therap., 28: 5-15.

CONNOR, B. AND DRAGUNOW, M., 1998. The role of neuronal growth factors in neurodegenerative disorders of human brain. Brain Res. Brain Res. Rev., 27: 1-39.

DAI, C. AND HOLLAND, E.C., 2003. Astrocytes differentiation states and glioma formation. Cancer J., 9: 72-81.

FOGDEN, F. AND NEUBERGER, J., 2001.Alternative medicines and the liver. Liver, 23: 213-220.

GRIEVE M. Ginseng. www.botanical.com/botanical/mgmh/g/ ginsen15.html.

HALL, P.A. AND WATT, F.M., 1989. Stem cells the generation and maintenance of cellular diversity. Development, 106: 619-633.

JEONG, S.M. AND NAH, S.Y., 2005. Ginseng and ion channels: Are ginsenoside, active component of panax ginseng, differential modulator of ion channels? J Ginseng Res., 29: 19-26.

KIEFER, D. AND PANTUSO, T., 2003. Panax ginseng. Am Fam Physic., 688:1539-42.

KITTS, D.D. AND HU, C., 2000. Efficacy and safety of ginseng. Publ. Hlth. Nutr., 3: 473-485.

KRUGER, G. AND MORRISON, S., 2002. Brain repair by endogenous progenitors. Cell, 110: 399-402.

KWON, J.H., LEE, G.D., BELANGER, J.M.R. AND PARE, J.R.J., 2003. Effect of ethanol concentration on the efficiency of extraction of ginseng saponins when using a microwave assisted process (MAPTM). Int. J. Fd. Sci. Technol., 38: 615-622.

LIU, P., XU, Y., YIN, H., WANG, J., CHEN, K. AND LI, Y., 2005. Developmental toxicity research of ginsenoside Rb1 using a whole mouse embryo culture model: Birth Defects. Res. B (Dev. Reprod. Toxicol.), 74: 207-209.

LIU, P., YIN, H., XU, Y., ZHANG, Z., CHEN, K. AND LI, Y., 2006. Effects of ginsenoside Rg1 on post implantation rat and mouse embryos cultured in vitro. Toxicol. in vitro. 20: 234-248.

NAH, SY., 1997. Ginseng: recent advances and trend. Korea J Ginseng Sci., 21: 1-12.

ONG, C.O., CHAN, L.Y., YUNG, P.B. AND LEUNG, T.N., 2005. Use of traditional Chinese herbal medicine during pregnancy: a prospective survey. Acta Obstet. Gynecol. Scand., 84: 699-700.

SHI, Q., HAO, QI, BOUISSAC, J., LU, Y., TIAN, S. AND LUU, B., 2005. Ginsenoside-Rd from Panax notoginseng enhances astrocyte differentiation from neural stem cells. Life Sci., 76: 983-995.

SHIBATA, S., 2001. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J. Korean med. Sci., 16 (suppl): S28 - S37.

THE EUROPEAN AGENCY FOR THE EVALUATION OF MEDICINAL PRODUCTS, 1999. Ginseng. Proc. Commit. Vet. med. Prod., (669/99-Final); London.

VA'ZQUEZ, L.F. AND AGUERA-ORTIZ, 2002. Herbal products and serious side effects: a case of ginseng-induced manic episode. Acta Psychiatr. Scand., 105: 76-78.

WEISSMANN, I., 2000. Stem cells units of development, units of regeneration, and units in evolution. Cell, 100: 157-168.

WILSON, K, KLEIN, J., SESSELBERG, T., YUSSMAN, S., MARKOW, D., GREEN, A., WEST, J. AND GRAY, N., 2006. Use of complementary medicine and dietary supplements among US adolescents. J. Adolescent Hlth., 38: 385-394 (Received, 17 April 2009, revised 4 December 2009)

Department of Anatomy, University of Health Sciences, Khiaban-e-Jamia Punjab, Lahore-54600, Pakistan (SK, MT), and The University of Wah, The Mall, Wah Cantt. Pakistan (KPL)
COPYRIGHT 2010 Asianet-Pakistan
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Pakistan Journal of Zoology
Article Type:Report
Geographic Code:9PAKI
Date:Oct 31, 2010
Words:2951
Previous Article:Accumulation of Toxic and Essential Trace Metals in Fish and Prawns from Keti Bunder Thatta District, Sindh.
Next Article:Isolation and Characterization of Cr6+ Reducing Bacteria and Their Potential Use in Bioremediation of Chromium Containing Wastewater.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters